首页 › 基金 › Boussard & Gavaudan Investment Management LLP › ANIP
Boussard & Gavaudan Investment Management LLP 对 ANIP 的持仓历史
ANI PHARMACEUTICALS INC COM · 医疗保健
Boussard & Gavaudan Investment Management LLP 在 Q1 2026 的 13F 申报中披露持有 ANIP(ANI PHARMACEUTICALS INC COM)13,350 股,市值约 US$16.5M,约占其申报组合的 1.80%,在其申报持仓中市值排名第 16 位。 Boussard & Gavaudan Investment Management LLP 最近 3 个申报季度中有 3 个季度披露了 ANIP 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR
Boussard & Gavaudan Investment Management LLP 对 ANIP 的持仓演变
Boussard & Gavaudan Investment Management LLP 于 Q3 2025 首次披露 ANIP 持仓:10,000 股(约 US$14.1M)。 该持仓在 Q4 2025 达到峰值 18,500 股,市值约 US$23.6M。 在 3 次申报中,Boussard & Gavaudan Investment Management LLP 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q1 2026)显示持股 13,350 股、市值约 US$16.5M,环比减持 -5,150 股。。 持仓曾出现大幅变动:Q4 2025 增持约 85% (随后一个季度股价下跌 3%)、Q1 2026 减持约 28% (随后一个季度股价上涨 8%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 10.00K | $14.11M | 新进 |
| Q4 2025 | 18.50K | $23.58M | 增持 |
| Q1 2026 | 13.35K | $16.46M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ANIP 与 13F 数据
ANIP(ANI PHARMACEUTICALS INC COM)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 ANIP,申报仓位最大的包括:Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Global Alpha Capital Management Ltd. (US$46.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ANIP 的基金
- Soleus Capital Management, L.P. 867.76K 股 · $71.83M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 707.50K 股 · $58.57M · Q2 2026
- Global Alpha Capital Management Ltd. 558.00K 股 · $46.19M · Q2 2026
- Empyrean Capital Partners, LP 23.00M 股 · $29.75M · Q2 2026
- Ranger Investment Management, L.P. 343.15K 股 · $28.41M · Q2 2026
- HBK INVESTMENTS L P 20.15M 股 · $26.12M · Q2 2026
- Ikarian Capital, LLC 272.08K 股 · $22.52M · Q2 2026
- Jones Hill Capital LP 233.81K 股 · $19.35M · Q2 2026
- Penn Capital Management Company, LLC 207.36K 股 · $17.18M · Q2 2026
- BOUSSARD & GAVAUDAN GESTION SAS 13.00K 股 · $17.07M · Q2 2026
- Parkman Healthcare Partners LLC 202.91K 股 · $16.80M · Q2 2026
- ABSOLUTE INVESTMENT ADVISERS, LLC 11.72M 股 · $15.17M · Q2 2026
更多关于 Boussard & Gavaudan Investment Management LLP
常见问题
How long has Boussard & Gavaudan Investment Management LLP held ANIP?
Boussard & Gavaudan Investment Management LLP has disclosed ANIP holdings in 3 of the last 3 reported quarters, going back to Q3 2025.
What is Boussard & Gavaudan Investment Management LLP's current position in ANIP?
As of Q1 2026, Boussard & Gavaudan Investment Management LLP holds 13.35K shares of ANIP (ANI PHARMACEUTICALS INC COM), valued at $16.46M, representing 1.80% of its reported portfolio and ranking #16.
Has Boussard & Gavaudan Investment Management LLP been buying or selling ANIP?
In the latest 13F filing (Q1 2026), Boussard & Gavaudan Investment Management LLP reduced its position in ANIP. The position peaked in Q4 2025 at 18.50K shares.
Which other funds hold ANIP?
Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Global Alpha Capital Management Ltd., among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.